BioArctic (Sweden) Top Management
| BIOA-B Stock | SEK 189.60 4.20 2.27% |
BioArctic employs about 61 people. The company is managed by 10 executives with a total tenure of roughly 143 years, averaging almost 14.0 years of service per executive, having 6.1 employees per reported executive. Analysis of BioArctic's management performance can provide insight into the company performance.
| Gunilla Andersson Insider Director HR |
| Pr Gellerfors Insider Sr CoFounder |
BioArctic |
BioArctic Management Team Effectiveness
BioArctic's management efficiency ratios could be used to measure how well BioArctic manages its routine affairs as well as how well it operates its assets and liabilities.BioArctic Workforce Comparison
BioArctic AB is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 1,289. BioArctic holds roughly 61.0 in number of employees claiming about 5% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.03) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.03. BioArctic AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. BioArctic AB Price Series Summation is a cross summation of BioArctic price series and its benchmark/peer.
BioArctic Notable Stakeholders
A BioArctic stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BioArctic often face trade-offs trying to please all of them. BioArctic's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BioArctic's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Gunilla Andersson | Director HR | Profile | |
| Pr Gellerfors | Sr CoFounder | Profile | |
| Jan Mattsson | S Fin | Profile | |
| Christer Mller | VP Officer | Profile | |
| Gunilla Osswald | Chief Officer | Profile | |
| Pr Lannfelt | VP CoFounder | Profile | |
| Oskar Bosson | VP IR | Profile | |
| Frida Lekander | Head Marketing | Profile | |
| Johanna Flting | VP Research | Profile | |
| Harald Borgeke | Head Affairs | Profile |
About BioArctic Management Performance
The success or failure of an entity such as BioArctic AB often depends on how effective the management is. BioArctic management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BioArctic management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BioArctic management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BioArctic AB , a research intensive biopharmaceutical company, develops disease modifying treatments and diagnostics for neurodegenerative diseases in Sweden. BioArctic AB was founded in 1992 and is headquartered in Stockholm, Sweden. BioArctic is traded on Stockholm Stock Exchange in Sweden.
Please note, the presentation of BioArctic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioArctic's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BioArctic's management manipulating its earnings.
BioArctic Workforce Analysis
Traditionally, organizations such as BioArctic use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BioArctic within its industry.BioArctic Manpower Efficiency
Return on BioArctic Manpower
| Revenue Per Employee | 379.4K | |
| Revenue Per Executive | 2.3M | |
| Net Loss Per Employee | 2M | |
| Net Loss Per Executive | 12M |
Complementary Tools for BioArctic Stock analysis
When running BioArctic's price analysis, check to measure BioArctic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioArctic is operating at the current time. Most of BioArctic's value examination focuses on studying past and present price action to predict the probability of BioArctic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioArctic's price. Additionally, you may evaluate how the addition of BioArctic to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |